Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis.
about
Randomisation to protect against selection bias in healthcare trialsOral corticosteroids for stable chronic obstructive pulmonary diseaseRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialSkeletal muscle dysfunction in chronic obstructive pulmonary diseaseGlucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary diseaseCopd.Resident utilization of information technology.Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 updateAsthma versus chronic obstructive pulmonary disease--exploring why 'reversibility versus irreversibility' is no longer an appropriate approach.Stable chronic obstructive pulmonary disease.Are inhaled glucocorticosteroids effective in chronic obstructive pulmonary disease?Time course expression of Foxo transcription factors in skeletal muscle following corticosteroid administration.Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.Evaluation of a novel method to assess corticosteroid responsiveness in chronic obstructive pulmonary disease.Basic statistics for clinicians: 3. Assessing the effects of treatment: measures of associationBronchodilator reversibility testing in chronic obstructive pulmonary diseaseRandomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary diseasePrednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease?The role of systemic corticosteroids in acute exacerbation of chronic obstructive pulmonary disease.Inhaler therapy. What it means for children with asthma.Effects of nedocromil sodium in the treatment of non-allergic subjects with chronic obstructive pulmonary diseaseEnd-tidal arterial CO2 partial pressure gradient in patients with severe hypercapnia undergoing noninvasive ventilation.Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary diseaseExacerbation rate, health status and mortality in COPD--a review of potential interventionsPredictive value and utility of oral steroid testing for treatment of COPD in primary care: the COOPT study.Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary diseaseDrug treatment of COPD. Controversies about agents and how to deliver them.The outpatient diagnosis and management of chronic obstructive pulmonary disease: pharmacotherapy, administration of supplemental oxygen, and smoking cessation techniques.Meta-analysis of controlled trials of drug therapy in mild chronic asthma: the role of inhaled corticosteroids.Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.Glucocorticoid receptor expression in human bronchial epithelial cells: effects of smoking and COPD.Current issues in the management of chronic obstructive pulmonary diseases.Assessment and management of dyspnoea.Efficacy and safety of inhaled corticosteroids. New developments.Advanced Cancer and Comorbid Conditions: Prognosis and Treatment.Bronchodilator therapy for chronic obstructive pulmonary disease.Diagnosing chronic obstructive pulmonary disease. The importance of differentiating asthma, emphysema, and chronic bronchitis.Management of COPD. Early identification and active intervention are crucial.
P2860
Q24245576-CAAC827B-A4E4-4197-BCF2-CA11A0B5F2A2Q24246556-F45E82F1-FA13-4337-9F28-BA41FBCB369FQ24642534-524AB08D-8E54-4540-863A-63C524A14ED6Q24792076-5C5D0EE7-EC55-483E-8FB5-B8CE7449438FQ28761895-DBDD2AD4-9897-49E1-8D1D-01B2371F0EADQ31016356-B4B74151-8900-48D9-9661-D8C1959A7668Q31043500-00D687A2-C5AB-412F-B797-6DF72073C368Q33591899-416F7A16-E5CC-4F7C-B9C1-3825EAE8097BQ33640272-86B85ED9-652D-411F-8EAE-AF0D53218DFAQ33716242-1C2D8556-860B-4563-B3E9-0C3289E92F89Q33771475-F1EF0153-5192-4C2C-8004-4EFA2F66CF56Q33910776-BC6BDC54-175F-4C7A-BC6D-56AD64E69724Q34004412-1F24F128-77F7-4CAE-AA71-C5AD10CC47A2Q34195947-DBBF9D2A-98ED-422C-9548-68FB7795C009Q34278236-88764C33-0ADF-4E90-8ACC-511851C1A4AFQ34535816-293C65DF-24DA-452D-90E4-776189C39B53Q35532488-C9CE1484-D74A-49BF-B281-011A64832495Q35536091-7922AEEA-AD77-484D-B64A-566505718332Q35538249-5244F67B-B98A-4AB4-89EA-35477BDC64BFQ35627610-C55CC9BB-BED5-4692-8593-E11AF82954B8Q35627804-6A3556D6-C448-4847-9D37-0E7B4E58ECB4Q36406943-4AD37FE0-173B-4CD7-B798-17F58F8B7157Q36576643-0467586B-77B6-442E-B4A6-2F8F6ECB032AQ36726296-F06BE429-D758-49D7-AA1C-92F3D7441387Q36883464-264B748E-430E-4363-BEBD-6095F55E4FD2Q37236165-4C9223C8-F5AD-4995-9CDF-FED4B619883DQ37474556-B31EC7FB-2050-4506-A694-4574977789ECQ37686080-25925A93-E2F3-42F1-8D7F-840D6E60FF8CQ39503572-1FE2C218-D96F-4825-8049-6CC464235B65Q40496058-066A8AB1-4999-44A2-9579-BC4423B6D5A0Q40588151-1A8100AF-64D8-4B08-8AFD-8428E639C613Q40835380-08A0F788-3208-4662-8DF4-644A77F480ABQ40999322-8E96E53A-34C3-45E6-B8EA-177D54ABAF6EQ41662462-7890E3D3-10D0-4D92-AE87-BA29711982E8Q41678391-3A6A9873-D4C8-484F-8634-1ABEC80FE8CDQ41728966-383CA578-68BC-4949-A319-C2D5FC045305Q41729481-BDA55757-0928-48F9-A2E1-98D79B40B5AFQ41731148-6AB4D42D-39FF-4D64-BE92-C4D3A8700FAEQ41744837-289080B2-CEDE-491F-B3AC-E8373B5B7E73Q41744843-0813FD10-D841-456B-9A9E-CFFF0A3E68A1
P2860
Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. A meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@en
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@nl
type
label
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@en
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@nl
prefLabel
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@en
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@nl
P2093
P921
P1476
Oral corticosteroid therapy fo ...... nary disease. A meta-analysis.
@en
P2093
P304
P356
10.7326/0003-4819-114-3-216
P407
P577
1991-02-01T00:00:00Z